Tag Archives: comparative effectiveness

Beating the Comparative Effectiveness Drum: Keeping Time with the National Pharmaceutical Council

By Clark Herman | Published: June 12, 2013
Celebrating its 60th year, the National Pharmaceutical Council (NPC) has played a key role in defining and enacting solutions to some of pharma’s most pressing issues. NPC is not a formal trade association, nor is it an academic think tank, its mandate lies somewhere in between. Now, it is committed to a specific focus on [...]
Posted in R&D, Regulatory, Strategy, Technology | Also tagged , , , | Leave a comment

PCORI Launches Clinical Research Network to Support Trials, Outcomes Research

By Jill Wechsler | Published: April 30, 2013
The new National Patient-Centered Clinical Research Network funded by the Patient-Centered Outcomes Research Institute (PCORI) aims to provide patients and clinicians with useful information on treatment options and outcomes. By encouraging more comparative clinical effectiveness research (CER),  the program also has potential to support development of new drugs and devices, explained PCORI executive director Joe [...]
Posted in FDA, healthcare | Also tagged , , , , , , , , , , , , , | Leave a comment

New Roster of Players to Debate Comparative Effectiveness Standards

By William Looney | Published: January 25, 2011
Methodologies are the heart of any consistent approach to certifying comparative effectiveness for new medicines—semantics aside, it’s the way payers and providers are going to determine clinical “value” and, by subtle extrapolation, their cost against existing alternative therapies. Last week, the Patient Centered Outcomes Research Institute [PCORI] created through federal health reform legislation moved one [...]
Posted in People, Regulatory, healthcare, pricing | Also tagged , , | Leave a comment

Upcoming Webcast: The Unvarnished Truth about Comparative Effectiveness

By George Koroneos | Published: June 4, 2009
The mere mention of the term “comparative effectiveness” evokes a host of reactions among pharmaceutical manufacturers: confusion, skepticism, even fear. With President Obama calling for a national agency for comparative effectiveness, no one doubts that it is coming to healthcare—but what will it encompass? How will comparative effectiveness impact access to medications? What can manufacturers [...]
Posted in Webcast | Also tagged , , , , , , , , , | Leave a comment